NEW

FDA Plans eMDR System Updates

The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) plans to update the FDA’s electronic medical device reporting (eMDR) system to reflect updates to the FDA Form 3500A and other system enhancements. The FDA Form 3500A is...

FDA Clears GE Healthcare’s Deep Learning-Based MR Image Reconstruction

GE Healthcare has announced U.S. FDA 510(k) clearance of AIR Recon DL. “This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image...

GlobalData: Impact of COVID-19 on diagnostic imaging not as severe compared to other areas

The impact of COVID-19 on diagnostic imaging (DI) procedures will not be as severe compared to other therapy areas, such as aesthetics and dental, since only 38.7% of these procedures are elective and expected to drop due to the COVID-19 pandemic, according to...

FDA Approves Cerianna

PETNET Solutions Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna...

SIGNA Premier 510(k) Cleared by the US FDA

GE Healthcare has announced SIGNA Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available for sale in the U.S. SIGNA Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design new imaging tools, particularly to aid researchers in the detection of biomarkers for the potential diagnosis of mild Traumatic Brain Injury. SIGNA Premier delivers a new level of clinical performance with additional research-focused capabilities, especially for neurology and oncology research.

“We are thrilled to bring SIGNA Premier to clinicians,” said Eric Stahre, president and CEO of GE Healthcare MRI. “We believe that its advanced applications and breakthrough innovations will deliver research-focused clinical capabilities and wide-bore patient comfort. This new system will help clinicians push the boundaries of what’s possible with MR.”

SIGNA Premier features GE Healthcare’s latest, short-bore, high-homogeneity 3.0T superconductive magnet; the most powerful gradient system GE Healthcare has ever developed for a wide bore 3.0T system; and a new, digital RF transmit and receive architecture. Clinical and research applications benefit from this high-performance hardware as well as machine learning software that includes cloud analytics. SIGNA Premier is powered by the innovative SuperG gradient technology. The SuperG gradient coil introduces outstanding performance and superb stability, which is designed to deliver the performance of ultra-high-performance, research-class 60 centimeter MRI system in a 70 centimeter bore.

The RF technology of SIGNA Premier provides 146 independent receiver channels that allow the simultaneous acquisition of patient data from multiple high channel-density surface coils for faster scanning, higher image quality, and overall enhanced clinical performance compared to GE Healthcare’s previous generation MR systems.

The 48-channel Head Coil delivers improved clinical performance compared to GE Healthcare’s previous generation MR systems for virtually every patient. A fit-adaptable design addresses 99.99 percent of the population – including patients with extremely large heads and short necks – while preserving high signal-to-noise ratio (SNR) and outstanding image quality. Additionally, SIGNA Premier can perform a routine fast brain examination in under five minutes by leveraging HyperSense, a new speed scanning tool, delivering up to eight times faster scanning,” which is part of the HyperWorks application suite.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *